0,810  0,002  Melanin inhibitor
0,813  0,012  Transcription factor NF kappa B inhibitor
0,799  0,003  Skin whitener
0,770  0,020  Apoptosis agonist
0,691  0,032  Antiinflammatory
0,658  0,008  Antioxidant
0,560  0,026  Antibacterial
0,546  0,014  Antineoplastic (brain cancer)
0,544  0,016  Chemopreventive
0,491  0,017  Free radical scavenger
0,489  0,023  Sensitization
0,450  0,019  Antiparasitic
0,469  0,038  Prostate cancer treatment
0,453  0,028  AR expression inhibitor
0,444  0,021  Nitric oxide antagonist
0,434  0,011  Abortion inducer
0,447  0,024  ICAM1 expression inhibitor
0,472  0,054  TNF expression inhibitor
0,440  0,029  Antineoplastic (pancreatic cancer)
0,422  0,014  Antihelmintic
0,471  0,072  Caspase 9 stimulant
0,433  0,037  Antihypercholesterolemic
0,422  0,028  NOS2 expression inhibitor
0,457  0,064  Antidiabetic
0,457  0,064  Cyclophilin D inhibitor
0,419  0,028  Cardiovascular analeptic
0,451  0,066  Antineoplastic (breast cancer)
0,415  0,034  Lipoxygenase inhibitor
0,407  0,043  Antifungal
0,388  0,033  Antiprotozoal (Leishmania)
0,394  0,042  Antineoplastic (melanoma)
0,383  0,032  Proliferative diseases treatment
0,386  0,042  NOS3 expression inhibitor
0,381  0,040  Antineoplastic (glioma)
0,366  0,026  Antiulcerative
0,329  0,005  AMP-activated protein kinase stimulant
0,333  0,011  Neurotrophic factor enhancer
0,371  0,053  Caspase 3 stimulant
0,361  0,046  Antiosteoporotic
0,420  0,106  Alpha-glucosidase inhibitor
0,356  0,045  UGT1A9 substrate
0,346  0,036  Antiglaucomic
0,355  0,048  CTGF expression inhibitor
0,377  0,073  Immunosuppressant
0,326  0,026  UGT1A4 substrate
0,342  0,046  UGT2B4 substrate
0,331  0,037  UGT1A6 substrate
0,312  0,021  Antiacne
0,355  0,064  Bone diseases treatment
0,324  0,041  Vasodilator
0,378  0,097  Calcium channel L-type activator
0,313  0,033  UDP-glucuronosyltransferase substrate
0,352  0,073  Vasodilator, peripheral
0,308  0,030  UGT1A1 substrate
0,325  0,050  Chemoprotective
0,282  0,014  Cholesterol synthesis inhibitor
0,278  0,011  Antineoplastic antibiotic
0,328  0,064  Antineoplastic (ovarian cancer)
0,282  0,020  NOS3 expression enhancer
0,323  0,062  Analeptic
0,305  0,045  Antineoplastic (glioblastoma multiforme)
0,280  0,023  Protein-tyrosine phosphatase inhibitor
0,287  0,033  Hepatoprotectant
0,335  0,085  Antineoplastic (lung cancer)
0,253  0,004  Cathepsin L2 inhibitor
0,318  0,072  CYP2D6 substrate
0,253  0,011  Farnesoid X receptor antagonist
0,330  0,089  Antileukemic
0,309  0,072  Respiratory analeptic
0,333  0,096  Antiobesity
0,240  0,005  Papain-like protease (SARS coronavirus) inhibitor
0,252  0,020  UGT2B9 substrate
0,247  0,017  Protein-tyrosine phosphatase 1B inhibitor
0,296  0,069  Radioprotector
0,303  0,078  12-Lipoxygenase inhibitor
0,323  0,108  Antiprotozoal
0,245  0,036  Sepsis treatment
0,300  0,091  Cholesterol antagonist
0,228  0,021  DNA polymerase I inhibitor
0,237  0,030  UGT2B15 substrate
0,322  0,117  15-Lipoxygenase inhibitor
0,235  0,031  Interferon gamma antagonist
0,231  0,031  Lipid peroxidase inhibitor
0,252  0,055  Antihypertriglyceridemic
0,240  0,045  UGT2B7 substrate
0,267  0,072  Antiprotozoal (Trypanosoma)
0,211  0,019  Antihemorrhagic
0,272  0,080  CYP2C19 substrate
0,287  0,095  Apoptosis antagonist
0,201  0,010  TRPA1 agonist
0,297  0,109  CYP2C9 substrate
0,214  0,030  Monophenol monooxygenase inhibitor
0,235  0,056  VCAM1 expression inhibitor
0,196  0,022  Antifungal (Cryptococcus)
0,215  0,043  UGT1A3 substrate
0,236  0,064  Antiviral (HIV)
0,202  0,031  Catenin beta inhibitor
0,191  0,022  Microtubule formation inhibitor
0,199  0,030  SULT1A3 substrate
0,174  0,008  Lipase inhibitor
0,215  0,048  Dual specificity phosphatase inhibitor
0,222  0,056  Pneumotoxic
0,174  0,009  CDC25A inhibitor
0,270  0,111  Antithrombotic
0,230  0,072  Antihypotensive
0,236  0,081  Antineoplastic (cervical cancer)
0,191  0,035  Antifungal enhancer
0,194  0,039  Arachidonic acid antagonist
0,197  0,043  Antineoplastic (squamous cell carcinoma)
0,259  0,109  Interleukin 2 agonist
0,246  0,099  Cardioprotectant
0,154  0,007  Protein kinase C eta inhibitor
0,247  0,101  Antihypoxic
0,162  0,020  Estrogen antagonist
0,204  0,064  CYP2B6 inhibitor
0,190  0,051  Prostate disorders treatment
0,149  0,016  Estrogen receptor beta antagonist
0,224  0,091  Antineoplastic (non-small cell lung cancer)
0,208  0,075  Cytotoxic
0,146  0,014  Aromatase inhibitor
0,184  0,052  Antiviral (Influenza A)
0,278  0,146  CYP2C19 inhibitor
0,211  0,085  Antineoplastic (lymphoma)
0,225  0,103  Spasmolytic
0,145  0,022  Actinic keratosis treatment
0,128  0,008  5-Alpha-reductase inhibitor
0,237  0,119  Hepatic disorders treatment
0,127  0,011  SULT1A2 substrate
0,129  0,014  Bile acid receptor antagonist
0,200  0,086  Antineoplastic enhancer
0,227  0,117  Streptokinase A inhibitor
0,162  0,057  Contraceptive
0,227  0,122  Hypoxia-inducible factor 1 alpha inhibitor
0,127  0,025  SULT1E1 substrate
0,132  0,030  Protein kinase C delta inhibitor
0,162  0,062  Hair growth stimulant
0,136  0,036  UGT2B1 substrate
0,114  0,015  Estrogen agonist
0,193  0,094  Embryotoxic
0,139  0,041  Alcohol dehydrogenase substrate
0,243  0,145  Antiprotozoal (Plasmodium)
0,153  0,056  Neurotrophic factor
0,152  0,055  Cyclooxygenase 1 inhibitor
0,113  0,021  Na+ K+ transporting ATPase inhibitor
0,119  0,027  Antibiotic
0,126  0,034  Anabolic
0,178  0,089  Antiviral (Influenza)
0,202  0,115  Superoxide dismutase inhibitor
0,096  0,009  Estrogen receptor alpha agonist
0,187  0,101  Teratogen
0,119  0,034  Androgen antagonist
0,105  0,021  HIV-1 integrase (Strand Transfer) inhibitor
0,125  0,041  Electron transport complex I inhibitor
0,096  0,012  Estrogen receptor beta agonist
0,191  0,109  Cytostatic
0,237  0,155  Ulceration
0,160  0,079  Prostatic (benign) hyperplasia treatment
0,201  0,122  Lipoprotein disorders treatment
0,146  0,066  Amylase inhibitor
0,152  0,074  Antimutagenic
0,096  0,018  Postmenopausal disorders treatment
0,126  0,048  Choleretic
0,127  0,050  SULT1A1 substrate
0,100  0,023  Ca(v)3.1 blocker
0,109  0,035  Ornithine decarboxylase inhibitor
0,159  0,085  UGT2B10 substrate
0,132  0,058  Coagulant
0,163  0,090  Carcinogenic
0,096  0,024  Glycine receptor agonist
0,227  0,155  CYP3A4 substrate
0,141  0,070  Ca2+-transporting ATPase inhibitor
0,098  0,028  Estrogen receptor alpha antagonist
0,112  0,043  UGT2B11 substrate
0,224  0,157  Sodium/bile acid cotransporter inhibitor
0,120  0,057  Photosensitizer
0,091  0,030  HIV-1 integrase inhibitor
0,118  0,057  Aldehyde dehydrogenase substrate
0,092  0,031  Narcotic antagonist
0,139  0,081  Genotoxic
0,075  0,017  Postcoital contraceptive
0,135  0,079  Protein kinase stimulant
0,072  0,020  Dopamine transporter inhibitor
0,107  0,055  Sulfotransferase substrate
0,083  0,033  HIV-1 integrase (3'-Processing) inhibitor
0,108  0,058  Beta glucuronidase inhibitor
0,147  0,099  Dual specificity phosphatase 3 inhibitor
0,092  0,045  Inducible nitric-oxide synthase inhibitor
0,106  0,059  5-Lipoxygenase inhibitor
0,153  0,107  LDLR expression enhancer
0,136  0,091  Antiviral (Herpes)
0,046  0,005  Protein kinase C beta I inhibitor
0,098  0,058  Prolactin inhibitor
0,211  0,171  GST M1-1 substrate
0,046  0,007  Protein kinase C beta II inhibitor
0,061  0,023  Glucose-6-phosphate translocase inhibitor
0,105  0,067  DOPA decarboxylase inhibitor
0,139  0,102  Uterine stimulant
0,068  0,032  Transcription factor AP-1 inhibitor
0,175  0,140  Hypoglycemic
0,190  0,155  Tyrosine 3 hydroxylase inhibitor
0,065  0,030  Fatty acid synthase inhibitor
0,122  0,089  Histone deacetylase SIRT1 inhibitor
0,180  0,149  Antineoplastic (colorectal cancer)
0,173  0,143  Antineoplastic (colon cancer)
0,130  0,100  Eye irritation, high
0,028  0,003  4-Hydroxyphenylpyruvate dioxygenase inhibitor
0,064  0,040  Prostaglandin F2 alpha antagonist
0,057  0,035  Dihydroorotate oxidase inhibitor
0,163  0,141  Antineoplastic (renal cancer)
0,143  0,126  Non-steroidal antiinflammatory agent
0,144  0,127  P-glycoprotein inhibitor
0,097  0,080  Cystathionine beta-synthase inhibitor
0,056  0,042  Pregnane X receptor antagonist
0,022  0,010  Progesterone receptor B antagonist
0,091  0,079  Skin irritative effect
0,064  0,054  Protein kinase C alpha inhibitor
0,113  0,103  Acaricide
0,023  0,015  Prostaglandin F2 alpha agonist
0,037  0,029  Retinoid X receptor antagonist
0,182  0,176  Gastrin inhibitor
0,028  0,025  Prostaglandin D2 agonist
0,026  0,023  Retinoid X gamma receptor antagonist
0,048  0,046  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,031  0,030  Retinoid X alpha receptor antagonist
0,118  0,117  Heat shock protein 90 antagonist
0,103  0,103  Contraceptive female

